KASPA Receives 2026 GIP Plus Certification from the Thai FDA
Last updated: 9 Oct 2026
92 Views

KASPA Pharmaceutical (Thailand) Co., Ltd. has received 2026 GIP Plus(Good Importing practice Plus) certification from the Thai Food and Drug Administration. The certification reflects the company's commitment to effective import management, quality control, and consumer safety.
On 11 September 2026, the Thai FDA held an event to recognize health product importers that met Good Importing Practices Plus requirements. Twenty-eight importers received GIP Plus recognition at the event, including KASPA Pharmaceutical (Thailand) Co., Ltd.
On 11 September 2026, the Thai FDA held an event to recognize health product importers that met Good Importing Practices Plus requirements. Twenty-eight importers received GIP Plus recognition at the event, including KASPA Pharmaceutical (Thailand) Co., Ltd.
This certification marks another important milestone for KASPA and reflects the company's commitment to maintaining quality and safety throughout the health product import process.
Another Step Toward Higher Standards
For KASPA, GIP Plus certification reflects our continued work to improve every stage of our import operations, from management and quality control to the delivery of safe, quality health products to partners and consumers.
We will continue to strengthen operating standards, improve import efficiency, and maintain quality and safety throughout our processes. These efforts help build confidence among business partners, healthcare professionals, and consumers while supporting responsible long-term growth.
GIP Plus reflects KASPA's commitment to delivering quality health products through standardized, efficient, and well-managed import processes.
Another Step Toward Higher Standards
For KASPA, GIP Plus certification reflects our continued work to improve every stage of our import operations, from management and quality control to the delivery of safe, quality health products to partners and consumers.
We will continue to strengthen operating standards, improve import efficiency, and maintain quality and safety throughout our processes. These efforts help build confidence among business partners, healthcare professionals, and consumers while supporting responsible long-term growth.
GIP Plus reflects KASPA's commitment to delivering quality health products through standardized, efficient, and well-managed import processes.
Source: Thai Food and Drug Administration, Thai FDA Raises Import Standards with GIP Plus and Introduces the GIP Lane to Improve Efficiency, Reduce Time and Costs, and Protect Consumers.
อ่านข่าวต้นฉบับจากสำนักงานคณะกรรมการอาหารและยา (อย.)
อ่านข่าวต้นฉบับจากสำนักงานคณะกรรมการอาหารและยา (อย.)
Related Content
อีกหนึ่งความภาคภูมิใจของแคสป้า ฟาร์มาซูติคอล กับรางวัลเชิดชูเกียรติด้านการบริหารทรัพยากรบุคคลยอดเยี่ยม สะท้อนถึงความมุ่งมั่นในการพัฒนาบุคลากรและสร้างองค์กรอย่างยั่งยืน
รถพยาบาลกระบะพันธุ์แกร่ง RESCUE T1 พัฒนาโดย แคสป้า ฟาร์มาซูติคอลฯ และ เอส.เอส.เอส. ออโตโมทีฟฯ
นายอนุทิน ชาญวีรกูล รองนายกรัฐมนตรี ลงพื้นที่ชุมชนนางลิ้นจี่ เพื่อติดตามอาการผู้ป่วยโควิด-19


